                              317 of 998 DOCUMENTS



                                Plus Patent News

                           December 31, 2016 Saturday

Head Line: European Patent Office granted patent to DANA-FARBER CANCER INST INC
[US]; THE BRIGHAM AND WOMEN'S HOSPITAL INC [US]; CHILDREN'S MEDICAL CENTER CORP
[US]; THE TECHNICAL UNIV OF DENMARK [DK] titled as "METHODS FOR PREDICTING
ANTI-CANCER RESPONSE"

LENGTH: 179 words

DATELINE: New York


Munich: European Patent Office has granted patent no. EP3109325 on December 28,
2016, to DANA-FARBER CANCER INST INC [US]; THE BRIGHAM AND WOMEN'S HOSPITAL INC
[US]; CHILDREN'S MEDICAL CENTER CORP [US]; THE TECHNICAL UNIV OF DENMARK [DK]
titled as "METHODS FOR PREDICTING ANTI-CANCER RESPONSE"

Inventor(s): RICHARDSON ANDREA L [US]; WANG ZHIGANG C [US]; SILVER DANIEL P
[US]; SZALLASI ZOLTAN [US]; BIRKBAK NICOLAI JUUL [GB]; EKLUND ARON C [DK] +
(RICHARDSON, Andrea L, ; WANG, Zhigang C, ; SILVER, Daniel P

Applicant(s): DANA-FARBER CANCER INST INC [US]; THE BRIGHAM AND WOMEN'S HOSPITAL
INC [US]; CHILDREN'S MEDICAL CENTER CORP [US]; THE TECHNICAL UNIV OF DENMARK
[DK] + (Dana-Farber Cancer Institute, Inc, ; The Brigha

Priority number(s): US20100402116P 20100824 ; EP20110757992 20110819

According to the abstract published by the European Patent Office on its
website: "The invention is based, in part, on the identification of novel
methods for defining predictive biomarkers of response to anti-cancer drugs."



The patent was filed under Application No. EP20160166825 20110819


LOAD-DATE: January 3, 2017

LANGUAGE: ENGLISH

PUBLICATION-TYPE: Newswire


              Copyright 2016 Plus Media Solutions Private Limited
                              All Rights Reserved


